InsiderTrades

Form 4 for BAX Baxter International

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001062993-23-005843 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-03 2023-03-01 BAX ALMEIDA JOSE E COB, CEO, Pres A - Grant $0.00 +67.9K 413.1K +20% $0
D 2023-03-03 2023-03-01 BAX ALMEIDA JOSE E COB, CEO, Pres A - Grant $0.00 +281.4K 281.4K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $1 par value 2023-03-01 A A 67,884 $0.00 413,096 D — — (F1) The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
2 Derivative Stock Option (Right to Buy) 2023-03-01 A A 281,445 $0.00 281,445 D $39.06 · — to 2033-03-01 281,445 Common Stock, $1 par value (F2) The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.